Navigation Links
Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
Date:2/1/2013

PARSIPPANY, N.J., Feb. 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), announced today that it intends to release fourth quarter 2012 financial results on Tuesday, February 19, 2013, prior to the open of the U.S. financial markets.  The Company will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, February 19, 2013 to discuss its financial results.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573, and the Conference ID is 94810189.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

About Actavis, Inc.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

Actavis is the world's third-largest generics prescription drug manufacturer.  Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 coun
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
2. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
3. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
4. Zimmer Reports Fourth Quarter and 2012 Financial Results
5. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
6. Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after Market Close on Thursday, February 14
7. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
8. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
9. Danaher Reports Record Fourth Quarter 2012 Results
10. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
11. Thoratec Schedules Fourth Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... IRVINE, Calif., Aug. 4, 2015  Syneron Medical Ltd. (NASDAQ: ... announced financial results for the three month period ended June ... Recent Non-GAAP 1 Highlights: , ... constant currency. , North American product sales grew 45% ... in constant currency, including 14% product growth in the EMEA ...
(Date:8/3/2015)... 2015   The Intellectual Property and Science ... provider of intelligent information for businesses and professionals ... Pharmaceutical R&D Factbook , the biopharmaceutical industry,s leading ... declines in R&D, the analysis identifies a surge ... and forecasts sales to reach $1.3 trillion by ...
(Date:8/3/2015)... Aug. 3, 2015  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... financial results for the fiscal third quarter 2015 after ... The Company will also host a conference ... 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Investors ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Pharma Sales to Grow Beyond $1 Trillion 2Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... 2011 In a comparative pharmacokinetic (PK) study, ... of topiramate in development for the management of ... to twice-daily immediate-release topiramate (Topamax®*) in its extent ... food, demonstrated a slower absorption profile compared with ...
... Medical, Inc., the global leader in devices for clot removal ... the launch of the DAC® 070 Catheter. The DAC 070 ... DAC family, making it the most complete family of distal ... was the first in a new class of catheters known ...
Cached Medicine Technology:PK Study Comparing Upsher-Smith's Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia 2PK Study Comparing Upsher-Smith's Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia 3Concentric Medical Launches DAC® 070, A New Distal Access Catheter 2Concentric Medical Launches DAC® 070, A New Distal Access Catheter 3
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is ... health conditions, pictures and medical art can be essential. StayWell, a health solutions company, ... Krames Patient Education solutions have been used by physicians and other health care providers ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... today announced that Bruce McCalley joins its executive leadership team as Senior Vice ... sales success at technology companies and expanding global markets with a special emphasis ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... ... August 04, 2015 , ... Data2Life , a Tel ... to provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The ... regulatory filings (including the FDA and HealthCanada), social media and anonymized clinical electronic ...
(Date:8/4/2015)... ... August 04, 2015 , ... Half of consumers are considering ... is increasingly influential in their choice of practitioner, according to new survey data ... on Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments and ...
Breaking Medicine News(10 mins):Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... A unique global conference,focusing on the future ... - 10,2009. The HealthQuake Summit will present an ... and explore the ongoing and future seismic,"tremors" in ... policy, and,science/technology that will make the industry virtually ...
... for Passover, ATLANTA, April 14 As Americans ... Centers for Disease Control,and Prevention advises all travelers to ... a measles outbreak in Israel., Since September, more ... with about 700 cases in the cities of Jerusalem ...
... of needing to start treatment , , MONDAY, April 14 ... antioxidant urate in their blood appear to develop the symptoms ... a new report says. , The findings, published in the ... early laboratory studies about urate,s protective qualities and offer hope ...
... treated , , MONDAY, April 14 (HealthDay News) -- People ... headaches than those with normal blood pressure, a new ... the new research does not mean those with hypertension ... pressure medications. , The stiff arteries that are associated ...
... arthritis (RA) sufferers, the Medicare Prescription Drug Improvement ... better disease management with biologic drugs. Prior to ... of the tumor necrosis factor (TNF) inhibitors, ... brand name, Remicade. Since the MMA, most Medicare ...
... BMW NA, Henry Ford Health System, Kraft Foods ... VitalSpring Award-Winning,Health Benefits Solution to Drive Industry Standards ... HR and Benefits Executives is Scheduled for,April 22nd, ... for Wellness ROI,Inc. announced today that it has ...
Cached Medicine News:Health News:CDC Urges Travelers to Israel to Protect Themselves from Measles 2Health News:Elevated Urate Levels May Slow Parkinson's in Men 2Health News:High Blood Pressure May Be Buffer Against Headaches 2Health News:High Blood Pressure May Be Buffer Against Headaches 3Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 2Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 3Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 2Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 3
... Dynamics Corporation offers a quality ... infants to adults. Armboard covers ... material assuring easy cleaning while ... contamination. Choose from three options: ...
The Side Rail Socket fits all American-made tables with standard side rails. Fits accessories with flat mounting posts up to 1/4"W x 1"L. Attaches at rail ends or notches....
Stainless steel construction to withstand sterilization modalities (EtO, Steris®, and Sterrad®) Wide angle of view...
Stainless steel construction to withstand sterilization modalities (autoclave, EtO, Steris®, and Sterrad®) Fully autoclavable, with both distal and proximal ends uniquely soldered for longe...
Medicine Products: